No VCs, no problem: Building oNKo-innate into a immuno-oncology innovator
How Jai broke down barriers between academia and entrepreneurship to blaze a path for future biotech founders
oNKo-innate’s approach to building a team of academics into a successful immuno-oncology innovation company
Jai's experiences building a company without VC support and how that influenced oNKo-innate’s funding and partnerships strategy
Having earned his Ph.D from University of Melbourne in immunotherapy and breast cancer. Dr. Jai Rautela defined his mission at oNKo-Innate as curator and supporter of one the highest performing biotech teams out there with the goal of delivering curative cancer therapies for all patients.